Completed NA INTERVENTIONAL 1-arm NCT01903174

Study of AeroForm Tissue Expander for Breast Reconstruction (ASPIRE)

AeroForm Patient Controlled Tissue Expansion for Breast Reconstruction

Sponsor: AirXpanders, Inc.

Conditions Breast Cancer Breast Reconstruction

Interventions AeroForm Breast Tissue Expander

Updated 5 times since 2017 Last updated: Mar 21, 2014 Started: Jun 30, 2012 Primary completion: Sep 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer and Breast Reconstruction, this trial is completed. The trial is conducted by AirXpanders, Inc. and has accumulated 5 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AirXpanders, Inc.

Data source: AirXpanders, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Subiaco, Australia